Immune-checkpoint inhibitors have revolutionized cancer therapy, yet many patients either
do not derive any benefit from treatment or develop a resistance to checkpoint inhibitors …

Recent technological advances in nanoscience and material designing have led to the
development of point-of-care devices for biomolecule sensing and cancer diagnosis. In situ …

Immunotherapy has revolutionized cancer treatment, dramatically improving survival rates of
melanoma and lung cancer patients. Nevertheless, immunotherapy is almost ineffective …

Immunotherapy is a standard of care in many solid tumors but many patients derive limited
benefit from it. There is increasing interest toward tumor infiltrating lymphocytes (TILs) since …

The success of immunotherapeutic approaches strictly depends on the immune cells
interaction with cancer cells. While conventional in vitro cell cultures under-represent the …

Acute myeloid leukemia (AML) is a heterogeneous malignancy affecting myeloid cells in the
bone marrow (BM) but can spread giving rise to impaired hematopoiesis. AML incidence …

The continuing evolution of treatment options in thoracic oncology requires the pathologist to
regularly update diagnostic algorithms for management of tumor samples. It is essential to …

The central nervous system represents a complex environment in which glioblastoma
adapts skillfully, unleashing a series of mechanisms suitable for its efficient development …

The integration of artificial intelligence (AI) and positron emission tomography (PET) imaging
has the potential to become a powerful tool in drug discovery. This review aims to provide an …

Our previous study has demonstrated that the expression level of long noncoding RNA
(lncRNA)-differentiation antagonizing non-protein coding RNA (DANCR) increases in …